Deferred Income Tax Expense (Benefit) in USD of INTEGRA LIFESCIENCES HOLDINGS CORP from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Integra Lifesciences Holdings Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q1 2025.
  • Integra Lifesciences Holdings Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$1.83M, a 35.9% increase year-over-year.
  • Integra Lifesciences Holdings Corp annual Deferred Income Tax Expense (Benefit) for 2024 was -$20.7M, a 74.4% decline from 2023.
  • Integra Lifesciences Holdings Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$11.9M, a 159% decline from 2022.
  • Integra Lifesciences Holdings Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$4.59M, a 66.4% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)

INTEGRA LIFESCIENCES HOLDINGS CORP Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$1.83M +$1.02M +35.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-05
Q1 2024 -$2.86M -$4.81M -246% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-05
Q1 2023 $1.95M -$1.59M -44.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q1 2022 $3.54M +$4.78M Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q1 2021 -$1.23M -$6.3M -124% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q1 2020 $5.07M +$11.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q1 2019 -$6.84M -$5.21M -318% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 -$1.64M -$1.64M -23471% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q1 2017 $7K +$127K Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-26
Q1 2016 -$120K -$1.46M -109% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-26
Q1 2015 $1.34M -$222K -14.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-27
Q1 2014 $1.56M +$2.62M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-01
Q1 2013 -$1.06M -$72K -7.33% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q1 2012 -$983K +$998K +50.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q1 2011 -$1.98M -$1.61M -437% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q1 2010 -$369K Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28

INTEGRA LIFESCIENCES HOLDINGS CORP Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$20.7M -$8.85M -74.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 -$11.9M -$7.3M -159% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 -$4.59M -$1.83M -66.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2021 -$2.76M +$61.4M +95.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$64.1M -$45.1M -237% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 -$19M -$10.9M -133% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$8.18M +$59.1M +87.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
2017 -$67.3M -$60.8M -940% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 -$6.47M -$6.12M -1744% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 -$351K +$6.5M +94.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$6.85M -$5.51M -411% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
2013 -$1.34M -$2.88M -187% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $1.54M +$381K +33% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $1.16M -$2.97M -72% Jan 1, 2011 Dec 31, 2011 8-K 2014-06-20
2010 $4.13M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.